AFL
Aflac Incorporated
Dividend Growth | |
Min. Div. Growth Past 7 Yrs. ≥ 15%: 2.0% | |
Rolling 4-Yrs Div. Growth Past 7 Yrs ≥ 15%: 11.4% | |
Years of Div. Growth ≥ 15: 42 | |
Income Generation | |
Current Yield 2.0% ≥ 20-Yrs Treasury Yield 4.8% | |
Total Dividends ≥ 20-Yrs Treasury Coupons in 5 Yrs | |
Sustainability | |
Debt-To-Equity 0.25 ≤ 0.45 | |
Last 12Months Cash Payout 0.30 ≤ 0.6 | |
Profitability | |
5-Yr Avg. Return-on-Equity 15.8% ≥ 15% | |
Last 12Months Return-on-Equity 24.1% ≥ 15% | |
Last 12Months Net Profit Margin 27.7% ≥ 10% | |
Fair Value | |
Average 5-Yrs High Yield 3.8% | |
Current Price $102.7 ≤ High Yield Price $54.8 | |
Average 5-Yrs Price-to-Earning (P/E) 8.3 | |
Current Price $102.7 ≤ Average P/E Price $75.2 | |
Current Price $102.7 ≤ Fair Value $56.9 |
Company Description
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Dividend
Revenue
Earning
Free Cash Flow